Tuberculosis (TB)

Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs

Available in the following languages:

Supporting documents

Policy guidance on TB drug susceptibility testing (DST) of second-line drugs (SLD)
Guidelines for drug-susceptibility testing for second-line antituberculosis drugs for DOTS-plus [pdf 67kb]

Share

Email Twitter Facebook Google Delicious LinkedIn

More...

Print